Reduction of platinum(IV) prodrug model complex trans-[PtCl2(CN)4]2 − by a peptide containing cysteine and methionine groups: HPLC and MS studies

A novel intermediate was formed through substitution of one of the axially chloride ligands of Pt(IV) complex with the sulfur atom of the methionine residue in the peptide.75